Cita APA

Chakravarthy, U., Harding, S., Rogers, C., Downes, S., Lotery, A., Wordsworth, S., & Reeves, B. (2012). Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration.

Citación estilo Chicago

Chakravarthy, U., S. Harding, C. Rogers, S. Downes, A. Lotery, S. Wordsworth, and B. Reeves. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.

Cita MLA

Chakravarthy, U., et al. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.